|
End-of-day quote
Bulgaria S.E.
24/03/2026
|
5-day change | 1st Jan Change | ||
| 176.40 EUR | -11.91% |
|
-.--% | -7.43% |
| 09-28 | AbbVie Receives U.S. FDA Approval For JUVMO For Parkinson's Disease | CI |
| 09-28 | US drugmakers turn to China for licensing deals | RE |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Data source:
AbbVie Inc.(ABBV)
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Data source:
AbbVie Inc.(ABBV)
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
Data source:
AbbVie Inc.(ABBV)
EBIT
Dividend / Share (DPS)
Data source:
AbbVie Inc.(ABBV)
Cash or Net Debt
- Stock Market
- Stocks
- ABBV Stock
- 4AB Stock
- Consensus AbbVie Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
